CODY GIBBS: Open Payments
NPI 1205335510 · CANTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,627 in 93 payments from 19 companies in 2025. Trend: 2023 $1,305 · 2024 $1,732 · 2025 $1,627
Food & beverage: $1,607Long term medical supply or device loan: $20
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 14 | $243 |
| ABBVIE INC. | 12 | $237 |
| Novartis Pharmaceuticals Corporation | 13 | $184 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $165 |
| PFIZER INC. | 11 | $140 |
| Novo Nordisk Inc | 5 | $99 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Abbott Laboratories | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
Products named: ZENPEP, CAPLYTA, LEQVIO, VRAYLAR, NURTEC ODT, JARDIANCE, Kerendia, LINZESS.
Industry payments across IL — which companies pay providers there.
